Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yalin Dong

Showing results (41-50 of 165) with videos related to

Pageof 17
Sort By:
Oncotarget|October 15, 2016
A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibilityYajing Zhai, Zhijun Dai, Hairong He, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2014
Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patientsHaiyan Dong, Jiao Xie, Lihong Chen, et al.
European Journal of Clinical Pharmacology|April 6, 2017
Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery diseaseYajing Zhai, Hairong He, Xiancang Ma, et al.
European Journal of Medicinal Chemistry|October 10, 2015
Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amineYuanyuan Shan, Jinyun Dong, Xiaoyan Pan, et al.
Frontiers in Oncology|May 30, 2019
Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast CancerSiying Chen, Yang Liu, Jin Yang, et al.
Breast Cancer (Tokyo, Japan)|May 31, 2019
Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcomeRuifang Hao, Yang Liu, Qian Du, et al.
European Journal of Clinical Pharmacology|May 8, 2024
Estimation of linezolid exposure in patients with hepatic impairment using machine learning based on a population pharmacokinetic modelRu Liao, Lihong Chen, Xiaoliang Cheng, et al.
Journal of Drug Targeting|October 11, 2016
SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathwayWeipeng Zhang, Xiaowei Zheng, Ti Meng, et al.
International Immunopharmacology|February 26, 2013
Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in ratsJianfeng Xing, Cuiyu You, Kai Dong, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2020
Dosage regimen and toxicity risk assessment of linezolid in sepsis patientsLinjie Dou, Dandan Meng, Yalin Dong, et al.
Pageof 17

Showing results (41-50 of 165) with videos related to

Sort By:
Pageof 17
Oncotarget|October 15, 2016
A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibilityYajing Zhai, Zhijun Dai, Hairong He, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2014
Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patientsHaiyan Dong, Jiao Xie, Lihong Chen, et al.
European Journal of Clinical Pharmacology|April 6, 2017
Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery diseaseYajing Zhai, Hairong He, Xiancang Ma, et al.
European Journal of Medicinal Chemistry|October 10, 2015
Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amineYuanyuan Shan, Jinyun Dong, Xiaoyan Pan, et al.
Frontiers in Oncology|May 30, 2019
Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast CancerSiying Chen, Yang Liu, Jin Yang, et al.
Breast Cancer (Tokyo, Japan)|May 31, 2019
Transgelin-2 expression in breast cancer and its relationships with clinicopathological features and patient outcomeRuifang Hao, Yang Liu, Qian Du, et al.
European Journal of Clinical Pharmacology|May 8, 2024
Estimation of linezolid exposure in patients with hepatic impairment using machine learning based on a population pharmacokinetic modelRu Liao, Lihong Chen, Xiaoliang Cheng, et al.
Journal of Drug Targeting|October 11, 2016
SET protein overexpression contributes to paclitaxel resistance in MCF-7/S cells through PI3K/Akt pathwayWeipeng Zhang, Xiaowei Zheng, Ti Meng, et al.
International Immunopharmacology|February 26, 2013
Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in ratsJianfeng Xing, Cuiyu You, Kai Dong, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2020
Dosage regimen and toxicity risk assessment of linezolid in sepsis patientsLinjie Dou, Dandan Meng, Yalin Dong, et al.
Pageof 17